Huston D P, McAdam K P, Balow J E, Bass R, DeLellis R A
Am J Med. 1981 Feb;70(2):320-3. doi: 10.1016/0002-9343(81)90768-3.
Amyloidosis occurs in a significant proportion of patients with rheumatologic diseases. The fibrillar amyloid proteins in such patients are composed predominantly of amyloid A protein, which is characteristic of the amyloid deposits associated with chronic inflammatory diseases. Only four patients with amyloidosis associated with systemic lupus erythematosus (SLE) have been described previously; analyses of their fibrillar amyloid proteins were not reported. We present herein, a patient with SLE and amyloidosis. Histochemical staining of our patient's renal tissue with Congo red demonstrated that the amyloid deposits contained amyloid A protein, as defined by permanganate sensitivity. In addition, the patient's serum contained increased concentrations of serum amyloid A proteins. In review, each of the previously described patients with amyloidosis associated with SLE had renal amyloid deposits, with diagnosis in three during evaluation of proteinuria. Thus, although rare, amyloidosis should be considered in the differential diagnosis of proteinuria in patients with SLE.
淀粉样变性在相当一部分风湿性疾病患者中出现。此类患者的纤维状淀粉样蛋白主要由淀粉样蛋白A组成,这是与慢性炎症性疾病相关的淀粉样沉积物的特征。此前仅报道过4例与系统性红斑狼疮(SLE)相关的淀粉样变性患者;未报告对其纤维状淀粉样蛋白的分析情况。我们在此报告1例患有SLE和淀粉样变性的患者。用刚果红对我们患者的肾组织进行组织化学染色显示,淀粉样沉积物含有淀粉样蛋白A,这由对高锰酸盐的敏感性来定义。此外,患者血清中血清淀粉样蛋白A的浓度升高。回顾发现,之前描述的每例与SLE相关的淀粉样变性患者均有肾淀粉样沉积物,其中3例在蛋白尿评估期间确诊。因此,尽管罕见,但在SLE患者蛋白尿的鉴别诊断中应考虑淀粉样变性。